l-Carnitine ameliorates congenital myopathy in a tropomyosin 3 de novo mutation transgenic zebrafish

BACKGROUND: Congenital myopathy (CM) is a group of clinically and genetically heterogeneous muscle disorders, characterized by muscle weakness and hypotonia from birth. Currently, no definite treatment exists for CM. A de novo mutation in Tropomyosin 3-TPM3(E151G) was identified from a boy diagnosed...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Biomed Sci
Главные авторы: Hsu, Po-Jui, Wang, Horng-Dar, Tseng, Yung-Che, Pan, Shao-Wei, Sampurna, Bonifasius Putera, Jong, Yuh-Jyh, Yuh, Chiou-Hwa
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2021
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7802209/
https://ncbi.nlm.nih.gov/pubmed/33435938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-020-00707-1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы